The foundation aims to nurture top research talent through grants for emerging and rising researchers
Photo credits: zverge / BigStock
The Novo Nordisk Foundation in Denmark, one of the world’s leading funders of pharmaceutical and biotechnology research, is investing €21.7 million to support emerging and rising Danish researchers in bioscience and basic biomedicine through two new grant programmes.
Both calls aim to strengthen Danish fundamental research that contributes to better health through new biological and biomedical insights, and submitted proposals must include projects anchored at a university, hospital or other non-profit research institution in Denmark. However, the funding amount differs significantly between the two programmes.
The Hallas-Møller Emerging Investigator grant has a total budget of DKK 50 million (€6.7…
Discover the latest in research funding every Tuesday with Funding Newswire. Dive into detailed articles with our monthly or yearly subscriptions or start with a free trial
NOTE: if you're a part of one of our Network member organisations, you get free access by signing up with your institutional email. Verify your eligibility here.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.